Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Open accessPublished version of a preprint
The DOI matches its Crossref record; 102 of the 103 references it cites were found in a registry or an index.
Abstract
In recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly associated with the microbiome composition in the gut. Parkinson’s disease (PD) is the most intensively studied neurodegenerative disease in this context. In this review, we performed a systematic evaluation of the published literature comparing changes in colonic microbiome in PD to the ones observed in other NDs including Alzheimer’s disease (AD), multiple system atrophy (MSA), multiple sclerosis (MS), neuromyelitis optica (NMO) and amyotrophic lateral sclerosis (ALS). To enhance the comparability of different studies, only human case-control studies were included. Several studies showed an increase of Lactobacillus, Bifidobacterium, Verrucomicrobiaceae and Akkermansia in PD. A decrease of Faecalibacterium spp., Coprococcus spp., Blautia spp., Prevotella spp. and Prevotellaceae was observed in PD. On a low taxonomic resolution, like the phylum level, the changes are not disease-specific and are inconsistent. However, on a higher taxonomic resolution like genus or species level, a minor overlap was observed between PD and MSA, both alpha synucleinopathies. We show that standardization of sample collection and analysis is necessary for ensuring the reproducibility and comparability of data. We also provide evidence that assessing the microbiota composition at high taxonomic resolution reveals changes in relative abundance that may be specific to or characteristic of one disease or disease group, and might evolve discriminative power. The interactions between bacterial species and strains and the co-abundances must be investigated before assumptions about the effects of specific bacteria on the host can be made with certainty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Akkermansia utilize mucin as a source of energy and may therefore reduce barrier function and increase exposure to more microbial substrates across the epithelial lining.44”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“There are up to 100 times more microbial genes, named the microbiome, than human genes in one individual [7].”
BackgroundKalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164 · cited 1×
“Since the Faecalibacterium prausnitzi species include a high diversity of strains, a strain-dependent classification and investigation would improve insight into the beneficial and harmful effects on the host [79].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137 · cited 2×
“Other methodical choices, like choosing between the different bead beating cell lysis instruments before metagenome analysis, influence this ratio up to threefold in favour of Bacteroides [55].”
BackgroundAre We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Sender, R., Fuchs, S., & Milo, R. (2016) · Cell · doi:10.1016/j.cell.2016.01.013 · Cited by 2,050
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Research works printed but not linked: 1
- He Z. Microarrays Caister Academic Press Wymondham, UK 2014
Cited by
Items 101–200 of 306
Zhou, H., Zhao, J., Liu, C., Zhang, Z., Zhang, Y., & Meng, D. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.153937 · Cited by 47
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Borrego-Ruiz, A., & Borrego, J. J. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112497 · Cited by 47
Su, Y., Liu, N., Zhang, Z., Li, H., Ma, J., Yuan, Y., Shi, M., Liu, J., Zhao, Z., Zhang, Z., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175029 · Cited by 44
Exploring Human-Genome Gut-Microbiome Interaction in Parkinson’s Disease
Wallen, Z. D., Stone, W. J., Factor, S. A., Molho, E., Zabetian, C. P., Standaert, D. G., & Payami, H. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00218-2 · Cited by 41
Caligiore, D., Giocondo, F., & Silvetti, M. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.09.007 · Cited by 47
Tao, J., An, Y., Xu, L., Wang, Y., Wang, C., Li, P., Li, M., Yan, D., Wang, M., Zhong, G., et al. (2023) · Food & Function · doi:10.1039/d2fo03379h · Cited by 40
Hewel, C., Kaiser, J., Wierczeiko, A., Linke, J., Reinhardt, C., Endres, K., & Gerber, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00113 · Cited by 39
Drosophila Model for Studying Gut Microbiota in Behaviors and Neurodegenerative Diseases
Chiang, M.-H., Ho, S.-M., Wu, H.-Y., Lin, Y.-C., Tsai, W.-H., Wu, T., Lai, C., & Wu, C. (2022) · Biomedicines · doi:10.3390/biomedicines10030596 · Cited by 44
“The beneficial effects of probiotic supplements and EGCG containing green tea on PD symptoms have been shown in flies [116,118].”
BackgroundThe neuromicrobiology of Parkinson’s disease: A unifying theory
Muñoz, M., Empadinhas, N., & Cardoso, S. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101396 · Cited by 39
“Members of the genus Prevotella have been described to be involved in H2S production, and as mentioned above, their abundance is underrepresented in PD patients gut microbiota (Gerhardt and Mohajeri, 2018; Scheperjans et al., 2015; van Kessel and El Aidy, 2019).”
InfluentialRecent advances in exosome-based nanodelivery systems for Parkinson's disease
Zhu, Y., Xi, Q., Liu, Y., Zhou, Y., Liao, J., & Wu, Q. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123548 · Cited by 50
Gut Microbiota and Disorders of the Central Nervous System
Vuotto, C., Battistini, L., Caltagirone, C., & Borsellino, G. (2020) · The Neuroscientist · doi:10.1177/1073858420918826 · Cited by 37
“However, a systematic evaluation of the published literature comparing changes in colonic microbiome between PD and healthy subjects highlighted inconsistencies at the phylum level (Gerhardt and Mohajeri 2018).”
BackgroundBicknell, B. T., Liebert, A. D., McLachlan, C. S., & Kiat, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010049 · Cited by 38
“…of consideration and the ratio was found to be reduced in patients with amyotrophic lateral sclerosis [38,39] and depression [40], a review paper [41] evaluating microbiomes among PD sufferers found no significant differences in the F:B ratio. the ratio was found to be reduced in patients with…”
Oral and intestinal dysbiosis in Parkinson's disease
Berthouzoz, E., Lazarević, V., Zekeridou, A., Jiménez, M. C., Debove, I., Aybek, S., Schrenzel, J., Burkhard, P. R., & Fleury, V. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.010 · Cited by 40
Leyrolle, Q., Decoeur, F., Brière, G., Amadieu, C., Quadros, A. R. A. D. A., Voytyuk, I., Lacabanne, C., Benmamar‐Badel, A., Bourel, J., Aubert, A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00793-7 · Cited by 40
Chiu, L. S., & Anderton, R. S. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15892 · Cited by 37
“Individuals with PD have consistently shown lower diversity in gut bacteria (Gerhardt & Mohajeri, 2018; Gorecki et al., 2019; Petrov et al., 2017; Scheperjans et al., 2015), particularly when beta-diversity was analysed.”
BackgroundIwaniak, P., Owe-Larsson, M., & Urbańska, E. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052915 · Cited by 34
Schmit, K. J., Garcia, P., Sciortino, A., Aho, V. T. E., Rodriguez, B. P., Thomas, M. H., Gérardy, J., Acha, I. B., Halder, R., Cialini, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113071 · Cited by 36
Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review
Garg, K., & Mohajeri, M. H. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110883 · Cited by 34
“( continued on next page ) K. Garg and M.H. Mohajeri Table 7 ( continued ) K. Garg and M.H. Mohajeri 2019; Chen and Lin, 2022; Gerhardt and Mohajeri, 2018; Li et al., 2019; Nuzum et al., 2020; Pellegrini et al., 2018; Rajput et al., 2021; Ryman et al., 2023; Zhang et al., 2022).”
Self-citationNutrition and Lifestyle Interventions for Managing Parkinson’s Disease: A Narrative Review
Lister, T. (2020) · Journal of Movement Disorders · doi:10.14802/jmd.20006 · Cited by 34
Evaluation of hypoglycemic effect, safety and immunomodulation of Prevotella copri in mice
Verbrugghe, P., Brynjólfsson, J., Jing, X., Björck, I., Hållenius, F. F., & Nilsson, A. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-96161-6 · Cited by 33
Kohn, N., Szopinska-Tokov, J., Llera, A., Beckmann, C. F., Vásquez, A. A., & Aarts, E. (2021) · Gut Microbes · doi:10.1080/19490976.2021.2006586 · Cited by 38
Ribeiro, M. M., Alvarenga, L., Cardozo, L., Baptista, B. G., Nascimento, D., Esgalhado, M., & Mafra, D. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00645-0 · Cited by 35
“Interestingly, although all strains can catabolize EA, only Gordonibacter and Ellagibacter can produce Uros [24].”
The Many Ages of Microbiome–Gut–Brain Axis
Ratto, D., Roda, E., Romeo, M., Venuti, M. T., Desiderio, A., Lupo, G., Capelli, E., Sandionigi, A., & Rossi, P. (2022) · Nutrients · doi:10.3390/nu14142937 · Cited by 34
Soni, D., Upadhayay, S., Dhureja, M., Arthur, R., & Kumar, P. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01510-2 · Cited by 31
“Approximately 77% of PD patients had lower levels of Prevotellaceae and higher levels of pathogenic bacteria, such as Enterobacteriaceae , Verrucomicrobiaceae , and E. coil , in their feces (Gerhardt and Mohajeri 2018).”
Casani-Cubel, J., Benlloch, M., Sanchis-Sanchis, C. E., Marín, R., Lajara-Romance, J. M., & Ortí, J. E. D. L. R. (2021) · Metabolites · doi:10.3390/metabo11020120 · Cited by 33
“When analyzing the impact of curcumin by means of these microbial changes, we can observe that it increases Prevotellaceae and Bifidobacterium, decreased in the most prevalent neurodegenerative diseases such as Parkinson’s disease, and yet it decreases enterobacteria [181] that are higher in ALS (in particular Escheri…”
BackgroundTrabjerg, M. S., Andersen, D. C., Huntjens, P., Oklinski, K. E., Bolther, L., Hald, J. L., Baisgaard, A. E., Mørk, K., Warming, N., Kullab, U. B., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02034-z · Cited by 34
Sultana, O. F., Hia, R. A., & Reddy, P. H. (2024) · Antioxidants · doi:10.3390/antiox13020202 · Cited by 32
Ilieva, N. M., Wallen, Z. D., & De Miranda, B. R. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116176 · Cited by 31
Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson’s Disease
Dănău, A., Dumitrescu, L., Lefter, A., Tulbă, D., & Popescu, B. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111663 · Cited by 31
“The greatest H2 producers are Firmicutes, a phylum that has been shown to be altered both in terms of relative abundance and composition in people with PD [20,21,75,81].”
BackgroundResearch Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease
Zhang, W., Ye, Y., Song, J., Sang, T., Xia, T., Xie, L., Qiu, X., Zeng, Q., & Luo, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206157 · Cited by 32
“↓ [28,29,31] Bifidobacterium Actinomycetota; Actinomycetes; Bifidobacteriales; Bifidobacteriaceae ↑ [28,29,31–33] Akkermansia Verrucomicrobiota; Verrucomicrobiae; Verrucomicrobiales; Akkermansiaceae ↑ [28,31,34] Aquabacterium Pseudomonadota; Betaproteobacteria; Burkholderiales; Burkholderiales…”
InfluentialKoh, Y., Lee, P., Kuo, Y., Nagabhushanam, K., Ho, C., & Pan, M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100434 · Cited by 29
Zhang, Y., Liang, H., Wang, Y., Cheng, R., Pu, F., Yang, Y., Li, J., Wu, S., Shen, X. P., & He, F. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00724-w · Cited by 30
“The relative abundance of Ruminococcus, which is a genus of anaerobic, Gram-positive bacteria in the class of Clostridia and is closely associated with Crohn’s disease [44], is significantly reduced in patients with PD [45, 46].”
BackgroundTrabjerg, M. S., Mørkholt, A. S., Lichota, J., Oklinski, M. K., Andersen, D. C., Jønsson, K., Mørk, K., Skjønnemand, M.-L. N., Kroese, L. J., Pritchard, C. E. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72638-8 · Cited by 32
Boeri, L., Perottoni, S., Izzo, L., Giordano, C., & Albani, D. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002043 · Cited by 28
Parasite infections, neuroinflammation, and potential contributions of gut microbiota
Alloo, J., Leleu, I., Grangette, C., & Pied, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1024998 · Cited by 31
“The GM harbors trillions of microbes (mostly bacteria); an adult human harbors around 200 to 300 different bacterial species, most of which are located in the ileum and the colon (60) and interact with each other (61).”
BackgroundRich, S. N., Klann, E. M., Bryant, V. E., Richards, V. L., Wijayabahu, A. T., BRYANT, K. J., Mai, V., & Cook, R. L. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100168 · Cited by 28
Parkinson's Disease and the Gut: Models of an Emerging Relationship
Bindas, A. J., Kulkarni, S., Koppes, R. A., & Koppes, A. N. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.071 · Cited by 28
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease
Susmitha, G., & Kumar, R. K. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109478 · Cited by 28
Impact of Appendectomy on Gut Microbiota
Бабаханов, А. Т., ДЖУМАБЕКОВ, А. Т., Zhao, A., Kuandykov, Y., Tanabayeva, S. B., Fakhradiyev, I. R., Nazarenko, Y., & Saliev, T. M. (2021) · Surgical Infections · doi:10.1089/sur.2020.422 · Cited by 28
Identification of plasmalogens in Bifidobacterium longum, but not in Bifidobacterium animalis
Mawatari, S., Sasuga, Y., Morisaki, T., Okubo, M., Emura, T., & Fujino, T. (2020) · Scientific Reports · doi:10.1038/s41598-019-57309-7 · Cited by 25
Cabanillas‐Lazo, M., Quispe‐Vicuña, C., Barja–Ore, J., Fernández-Giusti, A., Munive-Degregori, A., Retamozo-Siancas, Y., Guerrero, M. E., & Mayta‐Tovalino, F. (2022) · BioMed Research International · doi:10.1155/2022/4144781 · Cited by 26
“In addition to the report of intestinal dysbiosis present in PD patients [9, 10], the relationship between the alteration of speci fi c bacterial species with the clinical features of PD has been reported [11].”
Fu, Q., Huang, H., Ding, A., Yu, Z., Huang, Y., Fu, G., Huang, Y., & Huang, X. B. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.965653 · Cited by 25
Chen, Y., Chen, J., Wei, H., Gong, K., Meng, J., Long, T., JianFeng, G., Hong, J. K., Yang, L., Qiu, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172710 · Cited by 28
“muciniphila to multiple sclerosis (MS) (59, 60), PD (61, 62), AD (55, 63), stroke (64), epilepsy (65), and amyotrophic lateral sclerosis (ALS) (66) and increased A.”
BackgroundSong, S., Liu, J., Zhang, F., & Hong, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-72202-4 · Cited by 27
Yang, C., Qiao, Z., Xu, Z., Wang, X., Deng, Q., Chen, W., & Huang, F. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07323 · Cited by 25
Precision Nutrition and Gut–Brain Axis Modulation in the Prevention of Neurodegenerative Diseases
Tuigunov, D. N., Sinyavskiy, Y. A., Nurgozhin, T. S., Zholdassova, Z., Smagul, G., Omarov, Y., Dolmatova, O., Yeshmanova, A., & Omarova, I. (2025) · Nutrients · doi:10.3390/nu17193068 · Cited by 28
“…significant association between the phenomenon of dopaminergic therapy wear-off and an increase in Lactobacillus with a decrease in Blautia , while in dyskinesias no significant differences in the microbiota composition were observed after taking into account confounding factors [173].”
Giulio, P. (2021) · Archives of Clinical Gastroenterology · doi:10.17352/2455-2283.000094 · Cited by 29
Effects of bifidobacteria-produced exopolysaccharides on human gut microbiota in vitro
Liu, G., Chen, H., Chen, J., Wang, X., Gu, Q., & Yin, Y. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9572-6 · Cited by 29
Ahmed, L. A., & Al‐Massri, K. F. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220222105004 · Cited by 26
Song, Z., Zhang, X., Hong, M., Wu, Z., Luo, S., & Cheng, K. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105584 · Cited by 23
Yang, Z.-X., Zhang, Y., Wang, Q., Zhang, L., Liu, Y., Zhang, Y., Ren, Y., Zhou, C., Gao, H.-W., Zhang, N.-X., et al. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01150-2 · Cited by 23
Gut Microbiota and Endocrine Disorder
Li, R., Li, Y., Cui, L., Zheng, D., & Chen, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_9 · Cited by 24
Brain Aging and Gut–Brain Axis
Mohajeri, M. H. (2019) · Nutrients · doi:10.3390/nu11020424 · Cited by 23
“Such diagnostic change of the species is demonstrated for PD in our review article [13].”
BackgroundSelf-citationJia, X., Chen, Q., Zhang, Y., & Asakawa, T. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1296713 · Cited by 22
Moreno‐Arrones, Ó. M., Ortega-Quijano, D., Pérez‐Brocal, V., Fernández‐Nieto, D., Jiménez‐Hernández, N., Heras, E. L., Moyá, A., & Pérez‐García, B. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20411 · Cited by 25
Gong, H., Zeng, R., Li, Q., Liu, Y., Zuo, C., Ren, J., Zhao, L., & Lin, M. (2022) · International Ophthalmology · doi:10.1007/s10792-021-02190-5 · Cited by 26
“Interestingly, previous studies have indicated that Blautia also decreased significantly in Parkinson’s disease (PD) [17, 18], multiple system atrophy [19], and Sjögren syndrome [20] and that the symptom duration was correlated with its abundance.”
ResultChoi, J. G., Huh, E., Kim, N., Kim, D., & Oh, M. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217194 · Cited by 24
Chen, Q., Li, Z., Zhou, C., Feng, Y., Liu, Q., Zhou, D., Lu, X., Du, G.-S., Jian, D., Luo, H., et al. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00506-z · Cited by 22
Ho, P.-Y., Chou, Y.-C., Koh, Y., Lin, W., Chen, W. J., Tseng, A.-L., Gung, C.-L., Wei, Y., & Pan, M. (2024) · ACS Omega · doi:10.1021/acsomega.4c02514 · Cited by 22
Parkinson’s disease: Are gut microbes involved?
Bhattarai, Y., & Kashyap, P. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00058.2020 · Cited by 21
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
Takeshige‐Amano, H., Saiki, S., Fujimaki, M., Ueno, S., Li, Y., Hatano, T., Ishikawa, K., Oji, Y., Mori, A., Okuzumi, A., et al. (2020) · Movement Disorders · doi:10.1002/mds.28068 · Cited by 20
“The gut–brain axis might be a potential mechanism related to PD that affects infection, neuroinflammation, and the spread of alpha-synuclein.47 Gut microbiome profiles are changed in patients with PD compared with HCs.48-50 Likewise, the profiles of patients with PSP and MSA are similar to those of patients with PD.50…”
ResultInfluentialMarsiglia, R., Marangelo, C., Vernocchi, P., Scanu, M., Pane, S., Russo, A., Guanziroli, E., CHIERICO, F. D., Valeriani, M., Molteni, F., et al. (2023) · Microorganisms · doi:10.3390/microorganisms12010037 · Cited by 20
“It may play a pivotal role for future larger studies on adults and for new translating the issue to the IS pediatric disease.”
BackgroundTreatments in neurogenic bowel dysfunctions: evidence reviews and clinical recommendations in adults
Musco, S., Bazzocchi, G., Martellucci, J., Amato, M. P., Manassero, A., Putignano, D., Lopatriello, S., Cafiero, D., Paoloni, F. P., & POPOLO, G. D. (2021) · European Journal of Physical and Rehabilitation Medicine · doi:10.23736/s1973-9087.20.06412-6 · Cited by 19
Huang, S., Zhang, C., Xie, X., Zhu, Y., Song, Q., Ye, L., & Hu, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.006 · Cited by 19
Gut bacteria: an etiological agent in human pathological conditions
Islam, M. M., Mahbub, N. U., Hong, S., & Chung, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1291148 · Cited by 18
“…, and Lactobacillus are more abundant, and Faecalibacterium spp. , Coprococcus spp. , Blautia spp. , Prevotella spp., and Prevotellaceae are signi fi cantly reduced in the PD group compared with the corresponding populations in the control group (Gerhardt and Mohajeri, 2018; Bullich et al., 2019).”
ResultCheng, H.-W., Jiang, S., & Hu, J. (2019) · Oral Health by Using Probiotic Products · doi:10.5772/intechopen.86775 · Cited by 17
Lu, Y., Gao, X., Yang, N., Mohammed, S. A. D., Fu, J., Wang, T., Wang, C., Yuan, C., Lu, F., & Liu, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18045 · Cited by 18
“In this study, Clostridium and lachnoClostridium under the phylum Firmicutes in the model group decreased significantly, and Akkermansia increased significantly, which is also consistent with the research of Jing Sun [34], Sara Gerhardt [35], Zhe Zhao [36] and ASH can reverse Clostridium, Akkermansia changes.”
ResultYoung at Gut—Turning Back the Clock with the Gut Microbiome
Narasimhan, H., Ren, C. C., Deshpande, S., & Sylvia, K. E. (2021) · Microorganisms · doi:10.3390/microorganisms9030555 · Cited by 17
“has been observed in patients suffering from PD; however, the exact role of these bacterial populations in pathogenesis is still not understood [65].”
BackgroundApproaching precision medicine by tailoring the microbiota
Ryu, G., Kim, H., & Koh, A. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09859-3 · Cited by 17
Kong, Y., Wang, L., & Jiang, B. (2021) · Life · doi:10.3390/life11080855 · Cited by 18
Gut dysbiosis and homocysteine: a couple for boosting neurotoxicity in Huntington disease
Martínez‐Lazcano, J. C., González‐Guevara, E., Boll, M., & Cárdenas, G. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0164 · Cited by 16
Górecka-Mazur, A., Krygowska‐Wajs, A., Furgała, A., Li, J., Misselwitz, B., Pietraszko, W., Kwinta, B. M., & Yılmaz, B. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14846 · Cited by 17
Tsao, S., Yeh, T., Lin, Y., Pan, C., Lee, Y. K., Wu, C., & Huang, H.-Y. (2024) · Food & Function · doi:10.1039/d4fo02039a · Cited by 18
Chen, M., Zhang, Y., Hou, L., Zhao, Z., Tang, P., Sun, Q., Zhao, J., & Wang, Q. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00892-6 · Cited by 17
“PDpatientsandanimal modelsexhibited notablevariancesinboththe abundanceandcompositionofgutbacteriacomparedwithcontrols 22,23 .”
Diet and Gut Microbiome and the “Chicken or Egg” Problem
Daniel, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.828630 · Cited by 18
Cao, X., Du, Z.-R., Liu, X., Wang, X., Li, C., Zhou, S.-N., Liu, J.-R., Xu, P.-Y., Ye, J.-L., Zhao, Q., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115100 · Cited by 15
“However, inconsistent F/B ratios in PD patients have been reported in different clinical trials [37,38], making it an inappropriate biomarker for PD.”
Nassar, A., Kodi, T., Satarker, S., Gurram, P. C., Fayaz, S. M., & Nampoothiri, M. (2023) · Gene · doi:10.1016/j.gene.2023.147898 · Cited by 15
Zhou, X., Gao, Y. J., Wei, J., Luo, J., Wang, Y., Yue, M., Wang, B., Hong, D., Chen, T., & Fang, X. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105661 · Cited by 16
Yao, L., Yang, Y., Yang, X., & Rezaei, M. J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04151-2 · Cited by 16
“Intestinal dysbiosis is associated with a range of pathophysiological changes, affecting not only the gastrointestinal tract but also the enteric and central nervous systems, particularly in the context of PD [75].”
Verbrugghe, P., Aken, O. V., Hållenius, F. F., & Nilsson, A. C. (2021) · BMC Microbiology · doi:10.1186/s12866-020-02063-4 · Cited by 15
“copri were observed in obese women [7] and in subjects with neurodegenerative diseases [8] and childhood atopic dermatitis [9].”
BackgroundBacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis
Walker, A. C., Bhargava, R., Dove, A. S., Brust, A. S., Owji, A. A., & Czyż, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094807 · Cited by 18
Hutchinson, N. T., Wang, S. S., DOKHANCHI, J., Johnson, R. W., Buford, T. W., Allen, J. M., & Woods, J. A. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003051 · Cited by 15
Trabjerg, M. S., Andersen, D. C., Huntjens, P., Mørk, K., Warming, N., Kullab, U. B., Skjønnemand, M.-L. N., Oklinski, M. K., Oklinski, K. E., Bolther, L., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00450-y · Cited by 16
Sciuto, M., & Catanzaro, R. (2023) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2023.02134 · Cited by 16
“Thus the administration of probiotics containing Bi fi dobacterium could prevent or slow down the progression of PD to more severe stages [50].”
BackgroundRole of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease
Yan, Z., Li, R., Shi, W., & Yao, L. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01004-6 · Cited by 15
“There are growing evidences that the alterations of gut microbiota are presented in patients and animal models of PD (Gerhardt and Mohajeri 2018; Petrov et al. 2017; Sun and Shen 2018; Qian et al. 2018).”
BackgroundThe microbiota-gut-brain axis in Huntington's disease
Love, C. J., Masson, B. A., Gubert, C., & Hannan, A. J. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.06.005 · Cited by 15
Zhao, X., Xu, M., Zhao, Z., Wang, Y., Liu, Y., Zhang, T., Wan, X., Jiang, M., Luo, X., Shen, Y., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14165 · Cited by 16
Weinberg, R. P., Koledova, V. V., Subramaniam, A., Schneider, K., Artamonova, A., Sambanthamurthi, R., Hayes, K. C., Sinskey, A. J., & Rha, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-54461-y · Cited by 16
Boschetti, E., Neri, I., Follo, M. Y., GIORGIO, R. D., Cocco, L., Manzoli, L., & Ratti, S. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220622111501 · Cited by 14
Banerjee, A., Pradhan, L. K., Sahoo, P. K., Jena, K. K., Chauhan, N. R., Chauhan, S., & Das, S. K. (2021) · Archives of Microbiology · doi:10.1007/s00203-021-02276-9 · Cited by 14
Influence of Gut Microbiota on Behavior and Its Disturbances
Ignatova, V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85317 · Cited by 16
“Other studies registered reduction of microorganisms as Faecalibacterium, Coprococcus, Blautia, Prevotella and Prevotellaceae in gut of subjects, suffering from PD. These alterations are non-disease specific at a lower taxonomic level, for example at phylum stage, but at higher taxonomic level as genus or species, was…”
BackgroundThe Role of Gut Microbiota in Neuromyelitis Optica Spectrum Disorder
Yao, S., Yang, X., Cen, L., & Tan, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063179 · Cited by 13
“Specifically, the gut microbiota metabo-lizes through fermentation [34] and modifies host-derived metabolites to produce certain vitamins, fatty acids, amino acids, and polyamines essential for immune regulation [35].”
BackgroundAltered Blood Levels of Anti-Gal Antibodies in Alzheimer’s Disease: A New Clue to Pathogenesis?
Angiolillo, A., Gandaglia, A., Arcaro, A., Carpi, A., Gentile, F., Naso, F., & Costanzo, A. D. (2021) · Life · doi:10.3390/life11060538 · Cited by 13
Pesticides and the Gut Microbiota: Implications for Parkinson’s Disease
Ghosh, N., Sinha, K., & Sil, P. C. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00057 · Cited by 11
Wei, S., Chen, L., Yang, F.-Y., Yang, F., & Wang, S. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369102 · Cited by 12
“A disturbance in the intestinal flora is related to the occurrence and development of many neurodegenerative diseases (Bostanciklioğlu, 2018; Gerhardt and Mohajeri, 2018).”
Moreno, L. O., Bagüés, A., Martínez, V., & Abalo, R. (2023) · Nutrients · doi:10.3390/nu15122775 · Cited by 11
Oh my gut! Is the microbial origin of neurodegenerative diseases real?
Walker, A. C., & Czyż, D. M. (2023) · Infection and Immunity · doi:10.1128/iai.00437-22 · Cited by 12
“For example, clinical data reveal that the abundance of bacteria from the Prevotella genus negatively correlates with the pathogenicity and prevalence of different PCDs, including ALS (57), PD (58–66), and a mouse AD model (67).”
Endres, K. (2020) · Molecules · doi:10.3390/molecules25040925 · Cited by 11
“, [19,37]) will react in the same manner to the toxic peptides as compared to a “healthy” community or if an adaptation is achieved that lastly might explain the altered microbial composition.”
BackgroundGiulio, P. (2021) · Archives of Clinical Gastroenterology · doi:10.17352/2455-2283.000100 · Cited by 12
Dynamic changes of fecal microbiota in a weight-change model of Bama minipigs
Zeng, B., Chen, L., Kong, F., Zhang, C., Chen, L., Qi, X., Chai, J., Jin, L. G., & Li, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1239847 · Cited by 10
“Similarly, the abundance of Prevotellaceae was reduced in children consuming a western-style diet (high-fat and low fiber) (Davis et al., 2020), and also in patients with urinary and nervous system diseases (Gerhardt and Mohajeri, 2018; Sanada et al., 2020; Stanford et al., 2020).”
Background
Metadata
- Authors
- Gerhardt, S., & Mohajeri, M. H.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Mohajeri, M. Hasan
- ORCID
- Mohajeri, M. Hasan
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-06-01
- Volume
- 10
- Issue
- 6
- Pages
- 708
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6024871
- OpenAlex
- W2800577687
- Cited by
- 298
- References
- 103
- Citations by year
- 2026: 18 · 2025: 19 · 2024: 35 · 2023: 41 · 2022: 46 · 2021: 70 · 2020: 36 · 2019: 29 · 2018: 3
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Multiple Sclerosis Society
- EU Joint Programme – Neurodegenerative Disease Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Parkinson's disease, gut microbiota, colonic microbiota, neurodegenerative diseases, Alzheimer's disease, multiple system atrophy, multiple sclerosis, neuromyelitis optica, amyotrophic lateral sclerosis, Lactobacillus, Bifidobacterium, Akkermansia, Verrucomicrobiaceae, Faecalibacterium, Prevotella, synucleinopathies
- MeSH terms
- Gastrointestinal Microbiome, Humans, Intestinal Mucosa, Parkinson Disease, Research Design, Severity of Illness Index, Reproducibility of Results, Neuroimmunomodulation, Confounding Factors, Epidemiologic, Enteric Nervous System, Disease Progression, Evidence-Based Medicine, Neurodegenerative Diseases, Biomedical Research, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Methodical approach of systematic review due to PRISMA criteria (PRISMA criteria [33]).](https://figures.cochat.ai/paper-figures/9b939278a136418e9a3ebbc4669d8e86/changes-of-colonic-bacterial-composition-in-parkinson-s-disease-and-other-figure-1.jpg)